Third-Party Verified
Metabolic Research
Cat№ FYH-027
Retatrutide
10mg • Lyophilized
$139.92
USD / vial
Synthetic single-chain peptide engineered as a triple agonist with binding affinity at the GIP, GLP-1, and glucagon receptors. Supplied lyophilized for in vitro metabolic and endocrine receptor research. This lot was independently assayed by Janoshik Analytical — a third-party analytical laboratory — at 99.45% purity (Test #112477), with the full report published on this page. Supplied strictly For Research Use Only.
Technical Data
Catalog №
FYH-027
CAS №
2381089-83-2
Purity (HPLC)
99.45%
Mol. Weight
4731.33 g/mol
Mass / Vial
10mg
Form
Lyophilized
Storage
−20 °C, lyophilized
Origin
Switzerland, GMP-grade synthesis
Sequence / Structure
39-amino-acid GIP / GLP-1 / glucagon receptor triple agonist peptide
Independent Third-Party Certificate of Analysis
Click image to open full-resolution COA →
💳 Card & crypto checkout is launching soon. For now, every order is arranged securely with our verified specialist on Telegram (@FYHPeptides).
Related research compounds
More compounds researchers browse alongside Retatrutide.
